Related Experiment Video
Updated: May 29, 2026

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels
Published on: May 26, 2023
Mitral valve repair in a patient with myelodysplastic syndrome
Tadashi Omoto1, Masanori Hirota, Noboru Ishikawa
1Department of Surgery, Division of Thoracic and Cardiovascular Surgery, Showa University, Hatanodai 1-5-8, Shinagawa-ku, Tokyo, Japan. tomoto@med.showa-u.ac.jp
Abstract:
Open heart operations for patients with myelodysplastic syndrome (MDS) are associated with infective and bleeding complications. We report a 67-year-old woman with rheumatic, severe mitral regurgitation and mitral stenosis associated with MDS who underwent a mitral valve (MV) repair. Commissurotomy was performed in the anterior commissure. Autologous pericardial patch treated with glutaraldehyde solution was prepared. The anterior leaflet was completely detached from the posterior to the anterior commissure. The anterior leaflet was augmented by autologous pericardial patch treated with glutaraldehyde solution and three pairs of artificial chordae were implanted. Postoperative transesophageal echocardiography showed an increase in the MV orifice and less than trivial mitral regurgitation. Two years after the operation, the patient has normal sinus rhythm with no deterioration of the MV lesion by transthoracic echocardiography. Although the feasibility of MV repair is low in patients with restrictive pathology due to rheumatic disease, MV repair may be preferred in patients with MDS.
Insights
Mitral valve repair in patients with myelodysplastic syndrome (MDS) is feasible. This case study shows successful mitral valve repair in an MDS patient, offering a potential alternative to valve replacement.
Area of Science:
- Cardiovascular Surgery
- Hematology
Background:
- Open heart surgery in myelodysplastic syndrome (MDS) patients carries high risks of bleeding and infection.
- Rheumatic heart disease can lead to complex mitral valve pathologies, including severe mitral regurgitation and stenosis.
Observation:
- A 67-year-old female patient with rheumatic heart disease and myelodysplastic syndrome (MDS) presented with severe mitral regurgitation and stenosis.
- The patient underwent a complex mitral valve (MV) repair procedure involving commissurotomy, autologous pericardial augmentation, and artificial chordae implantation.
Findings:
- Postoperative echocardiography confirmed a significant increase in the MV orifice and only trivial mitral regurgitation.
- Two-year follow-up revealed normal sinus rhythm and stable mitral valve function without deterioration.
Implications:
- Mitral valve repair, despite challenges in rheumatic heart disease, may be a viable and preferred option for select MDS patients.
- This approach could potentially improve outcomes and reduce complications in MDS patients requiring cardiac surgery.
Related Concept Videos
Mitral Stenosis III: Medical Management
Mitral Regurgitation III: Medical Management
Mitral Stenosis I: Introduction
Mitral Valve Prolapse I: Introduction
Mitral Valve Prolapse II: Assessment and Management
Mitral Stenosis IV: Nursing Management

